You are here

Takeda

Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness push

Fierce Pharma

Wed, 03/31/21 - 10:49 am

eosinophilic esophagitis

Takeda taps BridGene to pursue hard-to-drug neurodegenerative disease targets

Fierce Biotech

Tue, 03/30/21 - 11:38 am

BridGene Biosciences

small molecule drugs

neurodegenerative disease

Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases

NASDAQ

Thu, 03/18/21 - 11:06 am

drug development

Vivek Ramaswamy's LNP delivery tech play Genevant scores $600M licensing deal from Takeda for nucleic acid therapies

Endpoints

Mon, 03/15/21 - 11:10 am

Vivek Ramaswamy

lipid nanoparticles

Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021

PR Newswire

Tue, 03/9/21 - 10:45 am

From partner to part of the family: Takeda pulls the trigger on Maverick buyout

Fierce Biotech

Tue, 03/9/21 - 10:32 am

Maverick Therapeutics

Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Fierce Pharma

Thu, 03/4/21 - 11:21 pm

non-small cell lung cancer

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin

Fierce Pharma

Wed, 03/3/21 - 12:01 am

A closely watched schizophrenia drug fails key test

BioPharma Dive

Tue, 03/2/21 - 11:54 pm

clinical trials

Early Morphic data hint at a threat to Entyvio

EP Vantage

Mon, 03/1/21 - 11:47 pm

Morphic Therpeuitc

Takeda's maribavir clears cytomegalovirus infections in phase 3

Fierce Biotech

Fri, 02/12/21 - 11:02 am

clinical trials

Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines

Fierce Biotech

Thu, 02/11/21 - 10:37 am

genomic medicine

Takeda GI veteran Parikh takes charge at 'molecular machines' biotech MOMA Therapeutics

Fierce Biotech

Mon, 02/1/21 - 10:30 am

MOMA Therapeutics

Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag

Endpoints

Thu, 01/28/21 - 10:41 am

non-small cell lung cancer

Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up

Endpoints

Tue, 12/15/20 - 08:22 pm

ASH: Takeda pads case for new leukemia use with 5-year survival data

Fierce Pharma

Tue, 12/8/20 - 12:11 am

BioCryst takes on Takeda, CSL with FDA approval for Orladeyo, the first pill to prevent HAE attacks

Fierce Pharma

Sat, 12/5/20 - 11:26 pm

Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks

Fierce Biotech

Fri, 12/4/20 - 11:00 am

clinical trials

Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study

Pharmaceutical Business Review

Wed, 12/2/20 - 10:24 am

clinical trials

COVID R&D Alliance

Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE

Endpoints

Wed, 11/18/20 - 11:07 pm

Pages